Bone Biologics Corporation
USD17.00
-0.50 (-2.86%)
CEO
Jeffrey Frelick
IPO Date
2021-10-13
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$18.80
Prev. Close
$17.50
Day Low
$17.00
Day High
$18.80
52W Low
$8.30
52W High
$35.95
Market Cap
$0.03B
| 12,500 |
| $3.61 |
| 10 Jan 2024 | Gagnon Robert E. | director | A-Award | Acquired | 8.006 | $4.68 |
| 10 Jan 2024 | Gagnon Robert E. | director | A-Award | Acquired | 9 | $4.68 |
| 10 Jan 2024 | Gagnon Robert E. | director | Disposed | 0 | $0.00 |
| 20 Sept 2023 | Lucera Erick | director | A-Award | Acquired | 85,763 | $0.64 |
| 14 Sept 2023 | Walsh Deina H | Chief Financial Officer | P-Purchase | Acquired | 8,000 | $0.64 |
| 12 Sept 2023 | Frelick Jeff | Chief Executive Officer | P-Purchase | Acquired | 9,500 | $0.69 |
| 7 Sept 2023 | Walsh Deina H | Chief Financial Officer | P-Purchase | Acquired | 6,700 | $0.71 |
| 7 Sept 2023 | Walsh Deina H | Chief Financial Officer | P-Purchase | Acquired | 300 | $0.70 |